CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
22.00
-0.05 (-0.23%)
Apr 2, 2025, 9:35 AM EDT - Market open

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6772,183---
Enterprise Value
9391,643---
Last Close Price
22.0528.68---
PS Ratio
1475.491916.94---
PB Ratio
2.292.98---
P/TBV Ratio
2.982.98---
EV/Sales Ratio
824.251442.48---
Debt / Equity Ratio
000.000.130.38
Asset Turnover
0.000.000.000.00-
Quick Ratio
34.7634.7613.179.328.97
Current Ratio
35.3035.3013.629.549.78
Return on Equity (ROE)
-19.18%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-15.02%-15.02%-19.97%-21.34%-
Return on Capital (ROIC)
-15.60%-15.60%-21.24%-22.42%-
Earnings Yield
-5.24%-4.03%---
FCF Yield
-4.70%-3.62%---
Buyback Yield / Dilution
-1466.47%-1343.03%-15.77%-2.48%-
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q